Since its discovery in the 1990s, “programmed cell death protein 1,” or PD-1, has been regarded as a leading target in cancer treatments.
COVID-19’s long reach: Some physical symptoms can persist up to two years post-diagnosis
Researchers investigated the prevalence rate of physical-type symptoms by the severity of acute COVID-19 beyond two years of diagnosis.
October 31, 2023